Vascular endothelial growth factor and bladder from a different perspective: not only an angiogenic factor

Area of Science:

• Developmental Biology
• Molecular Biology
• Urology

Background:

• Angiogenesis, the formation of new blood vessels, is essential for embryonic development and implicated in various diseases.
• Vascular Endothelial Growth Factor (VEGF) and its receptors (VEGFR-1, VEGFR-2) are key regulators of angiogenesis.
• VEGF-A, a prominent member of the VEGF family, plays a significant role in angiogenic processes.

Purpose of the Study:

• To review the molecular basis of angiogenesis, focusing on VEGF and its receptors.
• To discuss the critical roles of VEGF in embryonic bladder development.
• To highlight the expression patterns and angiogenic activity of VEGF in the developing embryonic bladder.

Main Methods:

• Literature review of studies on angiogenesis, VEGF, and embryonic bladder development.
• Analysis of existing research on VEGF expression and its downstream effects.
• Examination of previous experimental findings on exogenous VEGF and hypoxia-induced VEGF upregulation in bladder growth.

Main Results:

• VEGF-A is a major angiogenic factor, activating VEGFR-1 and VEGFR-2.
• VEGF-A contributes to normal embryonic bladder development.
• Exogenous VEGF or hypoxia-induced VEGF upregulation accelerates bladder growth via detrusor and urothelium hypertrophy and hyperplasia.

Conclusions:

• VEGF signaling is crucial for embryonic bladder development.
• VEGF-A's role extends beyond angiogenesis to direct bladder development.
• VEGF-mediated effects on detrusor muscle via hypoxia present a potential therapeutic strategy for urologic conditions like bladder outlet obstruction.